Clinical Trials Directory

Trials / Completed

CompletedNCT05623527

Clinical Characteristics and Prognosis of Acute Cerebrovascular Events Secondary to Patients Receiving Cardiac Electronic Implants

Clinical Characteristics and Prognosis of Acute Cerebrovascular Events Secondary to Patients Receiving Cardiac Electronic Implants (SOS-CARE) - A Multicenter Real-world Trial

Status
Completed
Phase
Study type
Observational
Enrollment
13,324 (actual)
Sponsor
First Affiliated Hospital Xi'an Jiaotong University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

To investigate the incidence, clinical characteristics and prognosis of acute ischemic and hemorrhagic cerebrovascular disease secondary to the implantation of cardiovascular implantable electronic devices, so as to provide a basis for subsequent treatment strategies and risk factor stratification. This study intends to retrospectively collect the incidence and case characteristics of acute cerebral infarction, cerebral embolism, transient ischemic attack and cerebral hemorrhage in CIED patients admitted to the First Affiliated Hospital of Xi 'an Jiaotong University and other centers from January 2012 to September 2022. Then, the incidence of poor prognosis and related factors of patients within 3 months were followed up by telephone to provide a basis for subsequent treatment strategy and risk factor stratification.

Conditions

Interventions

TypeNameDescription
DEVICEcardiac electronic implantsCardiac electronic implants(CIED) includes permanent pacemaker (PPM), implantable cardioverter defibrillator (ICD), three-chamber pacemaker for cardiac resynchronization therapy defibrillator, lead free pacemaker, etc.

Timeline

Start date
2022-11-20
Primary completion
2023-08-31
Completion
2023-09-30
First posted
2022-11-21
Last updated
2024-08-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05623527. Inclusion in this directory is not an endorsement.